| 11 |
Hanall Bio Pharm, Exporting New Diabetic Medicine “Glucodown Tab OR” to Iran
|
2015-03-09 |
admin |
1433 |
| 10 |
Hanall Bio Pharma, Conclusion of MOU for Korea Drug Development Fund Project of New Antibody Medicine against Autoimmunity Disease
|
2015-02-26 |
admin |
846 |
| 9 |
Hanall Bio Pharma, Applied the Clinical Trial Phase 1 for New Medicine of Dry Eye Diseases
|
2015-02-23 |
admin |
701 |
| 8 |
Hanall, Sponsoring Daily Supplies worth 17 million KRW for the neglected in pain of xerosis
|
2015-01-07 |
admin |
743 |
| 7 |
Hanall Bio Pharma, Sponsoring Medicines worth 82 million KRW to Community Chest of Korea
|
2015-01-07 |
admin |
685 |
| 6 |
Hanall Bio Pharma Received the “2014 Grand Prize of King Sejong Voluntary Service of Sharing”
|
2014-12-09 |
admin |
581 |
| 5 |
Hanall is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab”
|
2014-12-01 |
admin |
725 |
| 4 |
Hanall Bio Pharma, Achieving Surplus for Three Consecutive Quarters
|
2014-11-21 |
admin |
648 |
| 3 |
Hanall Completed the CGMP-class Production Plant for Cutting-edge Solid Formula
|
2014-07-10 |
admin |
681 |
| 2 |
Hanall Bio Pharma, Achieving Net Income of 540M KRW to Turn into Surplus
|
2014-05-23 |
admin |
646 |